Profusa (PFSA) Long-Term Deferred Tax (2021 - 2026)

Profusa (PFSA) posted quarterly Long-Term Deferred Tax of $146000.0 for Q1 2026, down 94.7% quarter-over-quarter from $2.8 million in Q4 2024.

Profusa (PFSA) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends

Profusa's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $146000.0 for Q1 2026.

In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $146000.0; the TTM figure through Mar 2026 stood at $146000.0 (changed N/A YoY), while the FY2024 annual figure was $2.8 million, up 80.55% from the prior year.
Long-Term Deferred Tax for Q1 2026 stood at $146000.0, down from $2.8 million in the prior quarter.
The five-year high for Long-Term Deferred Tax was $2.8 million in Q4 2024, with the low at $36940.0 in Q4 2022.
The 4-year median for Long-Term Deferred Tax is $836500.0 (2023), against an average of $1.1 million.
The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax jumped 4033.73% in 2023, then surged 80.55% in 2024.
Profusa's Long-Term Deferred Tax stood at $36940.0 in 2022, then surged by 4033.73% to $1.5 million in 2023, then surged by 80.55% to $2.8 million in 2024, then slumped by 94.7% to $146000.0 in 2026.
Business Quant data shows PFSA's Long-Term Deferred Tax at $146000.0 in Q1 2026, $2.8 million in Q4 2024, and $1.5 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Profusa	92,085.85	-282,914.15	-

Download Data